24/7 eTV BreakingNews Show : Danna maɓallin ƙara (hagu na hagu na allon bidiyo)
Rahoton Lafiya LGBTQ Labarai Labaran Amurka

Sakon gaggawa na CDC ga Amurkawan da aka yiwa allurar rigakafin: The Booster Shot

Mai Binciken Pfizer

Mutane miliyan 14 a Amurka waɗanda suka karɓi allurar Johnson da Johnson sun ji an manta da su kuma a baya. A yau wannan na iya canzawa tare da shawarar da ake jira na harbi mai ƙarfafawa sama da shekaru 18.

Print Friendly, PDF & Email
  • CDC, da Cibiyar Kula da Cututtuka da Cututtuka a Amurka ya ba da madaidaitan jagorori ga Amurkawa da saƙo na gaggawa lokacin da za a sami harbi na uku mai ƙarfi makonni 3 da suka gabata
  • Yana da mahimmanci a fahimci allurai na farko da na biyu na allurar COVID-19 yana ɗaukar fifiko akan kowane harbi mai ƙarfafawa
  • A yau kwamitin kwararru na waje a ranar Jumma'a ya shawarci Hukumar Abinci da Magunguna da ta ba da izinin ƙara yawan allurar rigakafin cutar coronavirus ta Johnson & Johnson ga mutane 18 da haihuwa.

Ma'aikatar Lafiya a cikin Jihohi 50 na Amurka suna ƙirƙirar sigar bayanan bayanan su da shawarwarin su, suna sanya batun gaba ɗaya rikitarwa kuma wani lokacin rikicewa

Babban, allurar COVID-19 guda biyu na Pfizer da Moderna yana ba da kyakkyawar kariya daga manyan alamu, asibiti, da mutuwa. Allurai na farko da na biyu na allurar rigakafin ya kamata su fifita kan kowane allurai masu ƙarfafawa. Hanya mafi kyau don kare iyalai da al'ummomi shine tabbatar da cewa mazauna marasa allurar rigakafi sun kammala jerin alluran rigakafin su na farko.

Yanzu ana ba da shawarar ɗaukar hoto na Pfizer don takamaiman ƙungiyoyin fifiko don haɓaka martanin rigakafin su ga COVID-19 da kuma ba da kariya daga cutar, gami da bambancin Delta.

Me yasa yakamata kuyi la’akari da mai ƙarfafawa?

Alluran rigakafin COVID-19 ya kasance mafi kyawun kayan aiki don hana rashin lafiya mai tsanani, asibiti, da mutuwa, gami da kariya daga bambance-bambancen Delta.

Koyaya, binciken da Cibiyar Kula da Cututtuka da Cututtuka (CDC) ta sake dubawa ya nuna cewa bayan an yi cikakken allurar rigakafin, kariya daga ƙwayar cutar da ke haifar da COVID-19 yana raguwa akan lokaci kuma yana ba da ƙarancin kariya daga bambancin Delta.

Wanene yakamata ya sami harbi mai ƙarfafawa?

Wasu mutane suna cikin haɗarin kamuwa da cuta ko rashin lafiya mai ƙarfi daga COVID-19 saboda shekarunsu, yanayin rashin lafiya, ko saboda suna rayuwa ko aiki kusa da wasu waɗanda ke jefa su cikin haɗarin haɗari don watsawa ko watsawa.

CDC ta ba da shawarar bayar da ƙarfafawa ga tsofaffi masu shekaru 65 zuwa sama da waɗanda shekarunsu suka kai 50 zuwa 64 tare da yanayin rashin lafiya saboda raguwar rigakafi a cikin waɗannan rukunin yana sanya su cikin haɗarin mafi girma ga rashin lafiya. Don haka, Ma'aikatar Lafiya a jihohi da yawa ta ba da shawarar cewa masu ba da lafiya su ba da fifiko ga waɗannan ƙungiyoyin.

Kamar yadda wadata masu haɓakawa ke ba da izini, CDC za ta ba da shawarwari don ƙarin ƙungiyoyi, gami da tsofaffi masu shekaru 18 zuwa 49 tare da yanayin rashin lafiya na asali dangane da fa'ida da haɗarin ga kowane mutum, da kuma tsofaffi masu shekaru 18 zuwa 64 waɗanda ke cikin haɗarin haɗari ga sana'a ko ma'aikata fallasawa, dangane da fa'idodi da haɗari ga kowane mutum.

Kamar yadda mazauna wurin suka yi haƙuri su jira lokacin su lokacin da aka fara samun allurar COVID-19 ya kamata duk mu nuna aloha kuma tabbatar da cewa ƙungiyoyin fifiko da aka ƙaddara sun karɓi ƙarfafawarsu na farko, wani ɓangare ne na koyarwar da aka ba mazauna cikin Jihar Hawaii.

Mai ƙarfafa Pfizer na waɗanda suka karɓi allurar Pfizer ne kawai; ba a ba da shawarar ga waɗanda suka karɓi allurar Moderna ko Johnson & Johnson.

Ana nazarin allurar rigakafin Moderna da Johnson & Johnson don allurar su mai ƙarfi kuma waɗanda aka yi wa allurar da ɗayan waɗannan alluran ya kamata su jira har sai FDA da CDC su ba da shawarwarin su. An riga an kammala matakin farko na wannan shawarar kuma yana jiran sanarwar hukuma.

Yaushe ya kamata ku sami mai ƙarfafawa?

Lokacin da aka ba da shawarar a halin yanzu don haɓaka Pfizer shine watanni shida bayan kun gama harbi biyu na farko. Bayanai daga gwajin asibiti sun nuna cewa harbi mai ƙarfafawa na Pfizer-BioNTech, wanda Hukumar Abinci da Magunguna ta amince da amfani da shi, ya nuna akwai ƙarin martani na rigakafi tsakanin mahalartan gwajin waɗanda suka kammala jerin alluran rigakafin Pfizer na su har tsawon watanni shida. a baya. 

yaya?

Ana samun allurar rigakafin OVID-19 ga masu karɓar allurar rigakafin Pfizer-BioNTech waɗanda suka kammala jerin farko aƙalla watanni 6 da suka gabata kuma sune:

Print Friendly, PDF & Email

Game da marubucin

Juergen T Steinmetz

Juergen Thomas Steinmetz ya ci gaba da aiki a masana'antar tafiye-tafiye da yawon buɗe ido tun yana saurayi a Jamus (1977).
Ya kafa eTurboNews a cikin 1999 azaman wasiƙar farko ta yanar gizo don masana'antar yawon shakatawa ta duniya.

Leave a Comment